ICI-198615 - CAS 104448-53-5
Catalog number:
104448-53-5
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C28H28N4O6S
Molecular Weight:
548.61
COA:
Inquire
Targets:
Leukotriene Receptor
Description:
ICI-198615 is a novel, potent and selective peptide leukotriene antagonist. It may be useful for the the treatment of allergic diseases.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98 %
Appearance:
Solid powder
Synonyms:
[1-[[2-Methoxy-4-[[(phenylsulfonyl)amino]carbonyl]phenyl]methyl]-1H-indazol-6-yl]carbamic acid cyclopentyl ester;Cyclopentyl N-[1-[[4-(benzenesulfonylcarbamoyl)-2-methoxyphenyl]methyl]indazol-6-yl]carbamate;ICI198615;ZM198615;ZM-198615
Solubility:
10 mM in DMSO
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
ICI-198615 may be useful for the the treatment of allergic diseases.
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
Melting Point:
181-182.5 °C
Density:
1.39±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
InChIKey:
YRCPIXCRSAKRGM-UHFFFAOYSA-N
InChI:
InChI=1S/C28H28N4O6S/c1-37-26-15-19(27(33)31-39(35,36)24-9-3-2-4-10-24)11-12-21(26)18-32-25-16-22(14-13-20(25)17-29-32)30-28(34)38-23-7-5-6-8-23/h2-4,9-17,23H,5-8,18H2,1H3,(H,30,34)(H,31,33)
Canonical SMILES:
COC1=C(C=CC(=C1)C(=O)NS(=O)(=O)C2=CC=CC=C2)CN3C4=C(C=CC(=C4)NC(=O)OC5CCCC5)C=N3
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Leukotriene Receptor Products


CAS 99107-52-5 U66858

U66858
(CAS: 99107-52-5)

U66858, also known as Bunaprolast, is a hydroquinone inhibitor of leukotriene synthesis, which inhibits LTB4 production in human whole blood.

Gemilukast
(CAS: 1232861-58-3)

This active molecular is an potent dual Leukotriene CysLT1 and CysLT2 Receptor antagonist originated by Ono Pharmaceutical. IC50 values is 1.7nM against human C...

CAS 118414-82-7 MK-886

MK-886
(CAS: 118414-82-7)

This active molecular is a leukotriene antagonist with the IC50 of 3 nM in human polymorphonuclear leukocytes. MK-886 also inhibits PPARα activation. Inhibition...

CAS 151767-02-1 Montelukast Sodium

Montelukast Sodium
(CAS: 151767-02-1)

Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.

LY 203647
(CAS: 122009-61-4)

LY 203647 is a a leukotriene D4 and E4 receptor antagonist with a tetrazole nucleus structure originated by Eli Lilly. No development for treatment of Ischaemic...

ONO-4057
(CAS: 134578-96-4)

ONO-4057 is a leukotriene B4 receptor antagonist originated by Ono Pharmaceutical. ONO-4057 is an Immunologic Factor and Immunosuppressive Agent. Clinical trial...

CAS 217799-03-6 KP496

KP496
(CAS: 217799-03-6)

KP496, a novel dual antagonist of cysLT receptor and TP, is currently in clinical development as a dry powder inhaler. KP496 inhibited epithelial hypertrophy an...

CAS 107753-78-6 Zafirlukast

Zafirlukast
(CAS: 107753-78-6)

Zafirlukast is in a class of medications called leukotriene receptor antagonists (LTRAs). It works by blocking the action of certain natural substances that cau...

LY 292728
(CAS: 153034-77-6)

LY 292728, an oxoxanthene derivative, has been found to be a leukotriene B4 receptor antagonist that has once been studied as an antiasthmatic agent.

CAS 111130-13-3 Cgp-35949

Cgp-35949
(CAS: 111130-13-3)

Cgp-35949 is an LTD4 antagonist which has phospholipase inhibitory activity. It represents a new approach to the treatment of asthma.

CP-199330 Sodium
(CAS: 158102-98-8)

The sodium salt form of CP-199330 which is a chromen derivative and has been found to be a Leukotriene D4 receptor antagonist that was once studied against asth...

CP-85958
(CAS: 134002-60-1)

This active molecular is a selective LTD4 antagonist. CP-85958 may become a clinical candidates for the treatment of asthma in the future.

CAS 148291-65-0 LY 210073

LY 210073
(CAS: 148291-65-0)

LY 210073, an oxoxanthene derivative, has been found to be a LTB4 receptor antagonist that could probably be effective against inflammation and rheumatic disord...

LY 245769
(CAS: 127345-02-2)

LY 245769 is a leukotriene E4 (LTE4) inhibitor, and it can inhibit the oxidative degradation of LTE4 and N-acetyl-LTE4 in animal model. LY 245769, as one of the...

CAS 943764-99-6 Acebilustat

Acebilustat
(CAS: 943764-99-6)

Acebilustat, formerly known as ZK322, is an oral anti-inflammatory designed to reduce the production of leukotriene B4 (LTB4),.

LY-256548
(CAS: 107889-31-6)

LY-25648 is a leukotriene B4 antagonist.

Ono-RS-347
(CAS: 103176-67-6)

Ono-RS-347 is an SRS-A antagonist and a new leukotriene antagonists.

CAS 117690-79-6 LY255283

LY255283
(CAS: 117690-79-6)

This active molecular is a competitive leukotriene B4 receptor antagonist and IC50 value is about 100 nM. LY 255283 is selective for the BLT2 receptor, since IC...

LY 213024
(CAS: 117423-95-7)

LY 213024 is a potent leukotriene B4 receptor antagonist. Agents which block the production of the leukotrienes have shown reduction of infarct size in animal m...

iralukast
(CAS: 125617-94-9)

Iralukast is a Leukotriene D4 receptor antagonist originated by Novartis as a a structural analogue of LTD4. It is applicated for the treatment of asthma and in...

Quick Inquiry

Verification code

Featured Items